Last month, a coroner’s court in Co Laois found that a 20-month-old child had died in 2023 after accidentally ingesting a patch used to administer the powerful painkiller fentanyl to a relative suffering from cancer. This was the first fentanyl-related death recorded in a child in Ireland, and a risk the company founded by prospective presidential candidate Gareth Sheridan aims to tackle. Such accidents, along with misuse of fentanyl by people addicted to the drug, are much more common in the US, where Sheridan’s Nutriband, Inc is aiming to commercialise its first product. Branded Aversa Fentanyl, the transdermal patch will…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .